特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
941643

BCGワクチンの世界市場(薬剤タイプ、最終用途、使用法、用途別):COVID-19の潜在的な影響に関する洞察と予測(2020年~2024年)

Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版日: | 発行: Koncept Analytics | ページ情報: 英文 97 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.41円
BCGワクチンの世界市場(薬剤タイプ、最終用途、使用法、用途別):COVID-19の潜在的な影響に関する洞察と予測(2020年~2024年)
出版日: 2020年06月11日
発行: Koncept Analytics
ページ情報: 英文 97 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のBCGワクチン市場は、2020年から2024年までの予測期間中に4.7%のCAGRで成長し、2024年には6,553万米ドルに達すると予測されています。同市場の主な成長要因には、結核の有病率の増加、結核に対するR&D資金の増加、膀胱癌の発生率の増加、広範な薬剤耐性結核の有病率の増加、BCG予防接種率の急増などが挙げられます。

当レポートは世界のBCGワクチン市場について調査しており、市場の成長要因、市場動向、課題、COVID-19の影響、薬剤タイプ・エンドユーザー・使用・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 市場概要

  • BCGワクチン
  • 医療用:結核
  • 医療用:癌
  • 医療用:マイコバクテリア
  • BCGの投与方法
  • BCGの悪影響
  • BCGで取られる予防策
  • BCGの副作用

第2章 COVID-19の影響

  • 世界の経済への影響
  • オーガニックトラフィックの変化
  • COVID-19の世界における流行

第3章 市場分析

  • 売上別:世界市場
  • 売上別:世界市場予測
  • 薬剤タイプ別
  • エンドユーザー別
  • 使用別
  • 用途別
  • 地域別

第4章 地域市場

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第5章 市場力学

  • 成長要因
    • 結核の急増
    • 結核調査開発資金の増加
    • 膀胱がんの発生率の上昇
    • 結核に対する米国における資金調達の急増
    • 広範な薬剤耐性結核の有病率の上昇
    • BCG予防接種の対象範囲の拡大
  • 主な動向・進展
    • 目標とする結核の発生率の低下
    • 結核の目標死亡率の減少
  • 課題
    • 成人に対するBCGの影響は限定的

第6章 競合情勢

  • 世界市場
    • 収益の比較:主要企業
    • 時価総額の比較:主要企業
    • 調査開発費の比較:主要企業
    • 世界市場シェアの比較:主要企業

第7章 企業プロファイル

  • Merck & Co.
  • Sanofi (Sanofi Pasteur)
  • Statens Serum Institut
  • China National Biotec Group (China National Pharmaceutical Group)
  • Serum Institute of India Pvt. Ltd. (SII)
  • Green Signal Bio Pharma Ltd.
図表

List of Charts

  • Medical Uses of BCG Vaccine
  • Medical Use of BCG: Mycobacteria
  • Medical Use of BCG: Mycobacteria
  • Side Effects of BCG
  • Organic Traffic Growth or Decline due to COVID-19 (2020)
  • Global COVID-19 Infected Cases (Jan'20 - May'20)
  • Global BCG Vaccine Market by Value (2015-2019)
  • Global BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Drug Type (2019)
  • Global Immune BCG Market by Value (2015-2019)
  • Global Immune BCG Market Forecast by Value (2020-2024)
  • Global Therapy BCG Market by Value (2015-2019)
  • Global Therapy BCG Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by End User (2019)
  • Global Pediatric BCG Vaccine Market by Value (2015-2019)
  • Global Pediatric BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Adult BCG Vaccine Market by Value (2015-2019)
  • Global Adult BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Usage (2019)
  • Global Tuberculosis BCG Vaccine Market by Value (2015-2019)
  • Global Tuberculosis BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Bladder Cancer BCG Vaccine Market by Value (2015-2019)
  • Global Bladder Cancer BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Application (2019)
  • Global Hospital BCG Vaccine Market Forecast by Value (2019-2024)
  • Global Clinic BCG Vaccine Market Forecast by Value (2019-2024)
  • Global BCG Vaccine Market by Region (2019)
  • North America BCG Vaccine Market by Value (2015-2019)
  • North America BCG Vaccine Market Forecast by Value (2020-2024)
  • Europe BCG Vaccine Market by Value (2015-2019)
  • Europe BCG Vaccine Market Forecast by Value (2020-2024)
  • Asia Pacific BCG Vaccine Market by Value (2015-2019)
  • Asia Pacific BCG Vaccine Market Forecast by Value (2020-2024)
  • ROW BCG Vaccine Market by Value (2015-2019)
  • ROW BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Prevalence of Tuberculosis (2014-2019)
  • Global TB Research & Development Funding (2013-2019)
  • Global Incidence of Bladder Cancer (2014-2019)
  • The US Funding for Global Tuberculosis (2014-2020)
  • Global Prevalence of Extensively Drug-Resistant Tuberculosis (2014-2019)
  • Global BCG Immunization Coverage Rate (2014-2019)
  • Global Targeted Incidence Rate of Tuberculosis (2015-2035)
  • Global Targeted Mortality of Tuberculosis (2015-2035)
  • Key Players - Revenue Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)
  • Key Players - R&D Expenses Comparison (2019)
  • Key Players - Global BCG Market Share Comparison (2019)
  • Merck & Co. Sales & Net Income (2015-2019)
  • Merck & Co. Sales by Segment (2019)
  • Merck & Co. Sales by Region (2019)
  • Sanofi Net Sales & Net Income (2015-2019)
  • Sanofi Net Sales by Segment (2019)
  • Sanofi Net Sales by Region (2019)
目次

The global BCG vaccine market is anticipated to reach US$65.53 million in 2024, growing at a CAGR of 4.70% during the period spanning 2020-2024. Growth in the global BCG vaccine market was driven by factors like increasing prevalence of tuberculosis, rising R&D funding on tuberculosis, growing incidences of bladder cancer, increasing prevalence of extensively drug resistant tuberculosis and surging BCG immunization coverage. The key trends that are expected to be faced by the market are declining targeted incidence rate of tuberculosis and decreasing targeted mortality of tuberculosis. The limited impact of BCG vaccine on adults is expected to impose a challenge on the global BCG vaccine market.

The global BCG vaccine market by drug type can be segmented as follows: immune BCG and therapy BCG. In 2019, the higher share of the market was held by immune BCG. The global BCG vaccine by end user can be segmented into the following pediatrics and adults. The dominant share of the market in 2019 was held by pediatrics. The market by usage can be divided into the following segments: tuberculosis and bladder cancer. The largest share of the market was obtained by tuberculosis in 2019. The global BCG vaccine market by application can be segmented as follows: hospitals and clinics, with hospitals holding a greater share of the market in 2019.

The global BCG vaccine market by region can be segmented into the following regions: North America, Europe and Asia Pacific. In 2019, the dominant share of the market was held by North America, followed by Europe and Asia Pacific. North America is predicted to dominate the market during the period spanning 2020-2024, supported by growing tobacco consumption and increasing technological advancements in BCG vaccination.

Scope of the report:

The report provides a comprehensive analysis of the global BCG vaccine market with potential impact of COVID-19.

The major regional markets (North America, Europe and Asia Pacific) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Merck & Co., Sanofi, Statens Serum Institut, China National Biotec Group (CNBG), Serum Institute of India Pvt. Ltd., Green Signal Bio Pharma Ltd) are also presented in detail.

Key Target Audience:

  • BCG Vaccine Providers/Hospitals
  • API Suppliers
  • End Users (Businesses/Consumers)
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1. BCG Vaccine
  • 1.2. Medical Use: Tuberculosis
  • 1.3. Medical Use: Cancer
  • 1.4. Medical Use: Mycobacteria
  • 1.5. Methods of Administration of BCG
  • 1.6. Adverse Effects of BCG
  • 1.7. Precautions to be taken in BCG
  • 1.8. Side Effects of BCG

2. Impact of COVID-19

  • 2.1. Impact on Global Economy
  • 2.2. Change in Organic Traffic
  • 2.3. Global Prevalence of COVID-19

3. Market Analysis

  • 3.1. Global BCG Vaccine Market by Value
  • 3.2. Global BCG Vaccine Market Forecast by Value
  • 3.3. Global BCG Vaccine Market by Drug Type
    • 3.3.1. Global Immune BCG Market by Value
    • 3.3.2. Global Immune BCG Market Forecast by Value
    • 3.3.3. Global Therapy BCG Market by Value
    • 3.3.4. Global Therapy BCG Market Forecast by Value
  • 3.4. Global BCG Vaccine Market by End User
    • 3.4.1. Global Pediatric BCG Vaccine Market by Value
    • 3.4.2. Global Pediatric BCG Vaccine Market Forecast by Value
    • 3.4.3. Global Adult BCG Vaccine Market by Value
    • 3.4.4. Global Adult BCG Vaccine Market Forecast by Value
  • 3.5. Global BCG Vaccine Market by Usage
    • 3.5.1. Global Tuberculosis BCG Vaccine Market by Value
    • 3.5.2. Global Tuberculosis BCG Vaccine Market Forecast by Value
    • 3.5.3. Global Bladder Cancer BCG Vaccine Market by Value
    • 3.5.4. Global Bladder Cancer BCG Vaccine Market Forecast by Value
  • 3.6. Global BCG Vaccine Market by Application
    • 3.6.1. Global Hospital BCG Vaccine Market Forecast by Value
    • 3.6.2. Global Clinic BCG Vaccine Market Forecast by Value
  • 3.7. Global BCG Vaccine Market by Region

4. Regional Market

  • 4.1. North America
    • 4.1.1. North America BCG Vaccine Market by Value
    • 4.1.2. North America BCG Vaccine Market Forecast by Value
  • 4.2. Europe
    • 4.2.1. Europe BCG Vaccine Market by Value
    • 4.2.2. Europe BCG Vaccine Market Forecast by Value
  • 4.3. Asia Pacific
    • 4.3.1. Asia Pacific BCG Vaccine Market by Value
    • 4.3.2. Asia Pacific BCG Vaccine Market Forecast by Value
  • 4.4. ROW
    • 4.4.1. ROW BCG Vaccine Market by Value
    • 4.4.2. ROW BCG Vaccine Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Surging Prevalence of Tuberculosis
    • 5.1.2. Increasing Research & Development Funding on Tuberculosis
    • 5.1.3. Rising Incidence of Bladder Cancer
    • 5.1.4. Upsurge in the US Funding for Tuberculosis
    • 5.1.5. Rising Prevalence of Extensively Drug-Resistant Tuberculosis
    • 5.1.6. Increasing BCG Immunization Coverage
  • 5.2. Key Trends & Developments
    • 5.2.1. Declining Targeted Incidence Rate of Tuberculosis
    • 5.2.2. Decreasing Targeted Mortality of Tuberculosis
  • 5.3. Challenges
    • 5.3.1. Limited Impact of BCG on Adults

6. Competitive Landscape

  • 6.1. Global Market
    • 6.1.1. Revenue Comparison- Key Players
    • 6.1.2. Market Capitalization Comparison- Key Players
    • 6.1.3. Research & Development Expenses Comparison - Key Players
    • 6.1.4. Global BCG Market Share Comparison - Key Players

7. Company Profiles

  • 7.1. Merck & Co.
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Sanofi (Sanofi Pasteur)
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Statens Serum Institut
    • 7.3.1. Business Overview
    • 7.3.2. Business Strategies
  • 7.4. China National Biotec Group (China National Pharmaceutical Group)
    • 7.4.1. Business Overview
    • 7.4.2. Business Strategies
  • 7.5. Serum Institute of India Pvt. Ltd. (SII)
    • 7.5.1. Business Overview
    • 7.5.2. Business Strategies
  • 7.6. Green Signal Bio Pharma Ltd.
    • 7.6.1. Business Overview
    • 7.6.2. Business Strategies
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.